These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6115041)

  • 41. Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Nakahara Y
    Biochem Pharmacol; 1974 Mar; 23(6):1073-8. PubMed ID: 4151050
    [No Abstract]   [Full Text] [Related]  

  • 42. Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
    Christian ST; McClain LD; Morin RD; Benington F
    Experientia; 1975 Aug; 31(8):910-11. PubMed ID: 125655
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of N,N-dimethyltryptamine and D-lysergic acid diethylamide on the release of 5-hydroxyindoles in rat forebrain.
    Randić M; Padjen A
    Nature; 1971 Apr; 230(5295):532-3. PubMed ID: 4927758
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo effect of LSD, morphine, ethanol and delta9-tetrahydrocannabinol on mouse brain adenosine triphosphatase activity.
    Jain ML; Curtis BM; Bakutis EV
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):229-32. PubMed ID: 4272745
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypothesis concerning the biosynthesis of lysergic acid.
    FELDSTEIN A
    Experientia; 1956 Dec; 12(12):475-6. PubMed ID: 13397535
    [No Abstract]   [Full Text] [Related]  

  • 46. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
    Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
    J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical abnormalities associated with schizophrenia.
    Smythies JR
    Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
    [No Abstract]   [Full Text] [Related]  

  • 48. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 49. Decreased number of benzodiazepine receptors in frontal cortex of rat brain following long-term lithium treatment.
    Hetmar O; Nielsen M; Braestrup C
    J Neurochem; 1983 Jul; 41(1):217-21. PubMed ID: 6306167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat.
    Fuxe K; Ogren SO; Agnati LF; Eneroth P; Holm AC; Andersson K
    Neurosci Lett; 1981 Jan; 21(1):57-62. PubMed ID: 6259561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
    Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
    [No Abstract]   [Full Text] [Related]  

  • 53. Certain aspects of drug distribution to brain.
    Oldendorf WH
    Adv Exp Med Biol; 1976; 69():103-9. PubMed ID: 941736
    [No Abstract]   [Full Text] [Related]  

  • 54. Biosynthesis of ergot alkaloids in Claviceps paspali. 3. Incorporation of 6-methyl-delta-8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H.
    Agurell S
    Acta Pharm Suec; 1966 Apr; 3(2):65-70. PubMed ID: 5946518
    [No Abstract]   [Full Text] [Related]  

  • 55. [Probable existence of D-lysergic acid diethylamide in infections caused by Toxoplasma gondii].
    VARELA G; VAZQUEZ A; TORROELLA J
    Rev Inst Salubr Enferm Trop; 1956 Dec; 16(4):29-32. PubMed ID: 13453992
    [No Abstract]   [Full Text] [Related]  

  • 56. [Research on the problem of schizophrenia using radiocarbon-labeled lysergic acid diethylamide & succinic acid].
    ARNOLD OH; HOFMANN G; LEUPOLDLOWENTHAL H
    Strahlentherapie; 1958; 107(Sonderbd. 38):59-65; discussion 66-7. PubMed ID: 13603137
    [No Abstract]   [Full Text] [Related]  

  • 57. Specific in vivo binding of d-LSD in rat brain.
    Kräuchi K; Feer H; Lichtsteiner M; Wirz-Justice A
    Experientia; 1978 Jun; 34(6):761-2. PubMed ID: 658293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem.
    Palacios JM; Probst A; Cortes R
    Brain Res; 1983 Sep; 274(1):150-5. PubMed ID: 6616253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies on the problem of schizophrenia. IV. Distribution of C-14-radioactive lysergic acid diethylamide (C-14-LSD 25) in the animal organism].
    ARNOLD OH; HOFMANN G; LEUPOLD-LOWENTHAL H
    Wien Z Nervenheilkd Grenzgeb; 1958; 15(1-4):15-27. PubMed ID: 13604283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.